Page 256 - Clinical Small Animal Internal Medicine

224 Section 3 Cardiovascular Disease

animals receiving ACEIs or ARBs. In many patients, Proof of improved survival in treated veterinary HT
VetBooks.ir improvement may be subtle, but noted by the patient’s patients is lacking, but because untreated TOD contrib-
utes to decreased quality of life, untreated HT may lead
owner as improvements in wakefulness, interest in eating
and interaction, and increased activity. Improvement in
general quality of life is reported in many patients. to euthanasia.

Further Reading

Acierno MJ, Brown S, Coleman AE, et al. ACVIM hypertension in client‐owned cats. J Vet Intern Med
consensus statement: Guidelines for the identification, 2015; 29(3): 786–93.
evaluation, and management of systemic hypertension Jepson RE. Feline systemic hypertension: classification and
in dogs and cats. J Vet Intern Med 2018; 32(6): 1803–22. pathogenesis. J Feline Med Surg 2011; 13(1): 25–34.
Coleman AE, Brown SA, Traas AM, et al. Safety and Sent U, Gössl R, Elliott J, Syme HM, Zimmering T.
efficacy of orally administered telmisartan for the Comparison of efficacy of long‐term oral treatment with
treatment of systemic hypertension in cats: results of a telmisartan and benazepril in cats with chronic kidney
double‐blind, placebo‐controlled, randomized clinical disease. J Vet Intern Med 2015; 29(6): 1479–87.
trial. J Vet Intern Med 2019; 33(2): 478–88. Stepien RL. Feline systemic hypertension: diagnosis and
Huhtinen M, Derré G, Renoldi HJ, et al. Randomized management. J Feline Med Surg 2011; 13(1): 35–43.
placebo‐controlled clinical trial of a chewable Syme H. Hypertension in small animal kidney disease. Vet
formulation of amlodipine for the treatment of Clin North Am Small Anim Pract 2011; 41(1): 63–89.